# ACP-103 to Treat Parkinson's Disease

> **NCT00086294** · PHASE2 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 40 (—)

## Conditions studied

- Parkinson's Disease
- Dyskinesias

## Interventions

- **DRUG:** Intravenous Levodopa
- **DRUG:** ACP-103

## Key facts

- **NCT ID:** NCT00086294
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06-25
- **Primary completion:** —
- **Final completion:** 2007-11-15
- **Target enrollment:** 40 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00086294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00086294, "ACP-103 to Treat Parkinson's Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00086294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*